MarkosWebWeb intelligence for the agentic economy

RyboDyn

Active

Unlocking the dark proteome for high-resolution immunotherapies

rybodyn.comAI readiness reportLinkedIn

What it does

Rybodyn unlocks the dark proteome to develop first-in-class immunotherapies with AI and high-resolution RNA sequencing via its RyboCypher™ platform.

Next to it in Healthcare and bio · immunotherapy protein discovery

  • Vitarka TherapeuticsSOSV SOSV IndieBio NY 05

    Targeting the undruggable

  • Diffuse BioY Combinator W23

    Generative AI for protein design

  • InvitrisY Combinator W23

    Creating new protein-based drugs at scale

  • Harmonic DiscoveryY Combinator S21

    Multi-targeted therapeutics to treat complex diseases

  • Olio LabsY Combinator S23

    Combination therapeutics for the world's toughest diseases

  • Kernal BiologicsY Combinator S20

    Kernal is creating mRNA 2.0 therapies that work in specific cells

  • Abalone BioY Combinator W20

    We create activating antibodies to treat diseases others can’t.

  • Algen BiotechnologiesY Combinator W20

    Using CRISPR to find treatments for cancer and inflammation